Immuneering Corp - Ordinary Shares Class A

NASDAQ:IMRX  
5.18
-0.25 (-4.60%)
4:00:26 PM EDT: $5.18 0.00 (0.00%)
Earnings Announcements

Immuneering Reports Third Quarter Results

Published: 11/10/2022 14:54 GMT
Immuneering Corp - Ordinary Shares Class A (IMRX) - Immuneering Reports Third Quarter 2022 Financial Results and Recent Business Highlights.
Q3 Loss per Share $0.49.
Cash, Cash Equivalents and Marketable Securities of $117.2m at Quarter End, Expected to Provide Cash Runway Into Q3 2024.
Q3 Earnings per Share View $-0.49 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.06 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $0.02 Million
Next Quarter EPS Guidance is expected to be -$0.61

More details on our Analysts Page.